US Stock MarketDetailed Quotes

TGTX TG Therapeutics

Watchlist
  • 16.850
  • +0.140+0.84%
Close May 28 16:00 ET
2.60BMarket Cap56.17P/E (TTM)

TG Therapeutics Key Stats

TG Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 1, 2024

Revenue(YoY)

63.47M

+713.46%
EPS(YoY)

-0.07

+75.00%

Buy

May 9, 2024

TG Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 77.985M--
--2024/Q2-- / 65.893M--
May 1, 20242024/Q163.474M / 54.608M--
Feb 28, 20242023/Q443.971M / 40.063M--
Nov 1, 20232023/Q3165.815M / 63.337M--
Aug 1, 20232023/Q216.074M / 17.947M--
May 1, 20232023/Q17.803M / 3.379M--
Feb 28, 20232022/Q480.000K / 1.604M--
Nov 10, 20222022/Q394.000K / 1.698M--
Aug 8, 20222022/Q2594.000K / 175.430K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 77.985M--
--2024/Q2-- / 65.893M--
May 1, 20242024/Q163.474M / 54.608M--
Feb 28, 20242023/Q443.971M / 40.063M--
Nov 1, 20232023/Q3165.815M / 63.337M--
Aug 1, 20232023/Q216.074M / 17.947M--
May 1, 20232023/Q17.803M / 3.379M--
Feb 28, 20232022/Q480.000K / 1.604M--
Nov 10, 20222022/Q394.000K / 1.698M--
Aug 8, 20222022/Q2594.000K / 175.430K--

Unlock Free Earnings Estimates

TG Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 9, 2024

Buy

  • Buy

    66.67%
  • Hold

    16.67%
  • Sell

    16.67%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg